Results 61 to 70 of about 29,343 (119)

Celiac Disease Emerging After ASCT in Multiple Myeloma: A Rare Diagnostic Intersection and Literature Review. [PDF]

Case Rep Hematol
Musleh M, Alswij MA, Alhusein Q.
europepmc   +1 more source

Daratumumab ± pomalidomide maintenance after salvage autologous transplantation in relapsed multiple myeloma: a phase 2 study. [PDF]

Blood Cancer J
Pasvolsky O, Costa BA, Aljawai YM, Patel KK, Bashir Q, Sui D, Srour SA, Tanner MR, Popat UR, Saini NY, Hosing C, Ramdial JL, Lee HC, Kaufman GP, Thomas SK, Weber DM, Becnel M, Tang G, Orlowski RZ, Champlin RE, Nieto Y, Shpall EJ, Qazilbash MH.   +22 more
europepmc   +1 more source

Isolated del(5q) with myeloproliferative driver mutations: A systematic review of published cases and clinical implications. [PDF]

Ther Adv Hematol
Abdulgayoom M, Al-Mashdali AF, Alshurafa A, Afana MS, Babiker AM, Bakheet M, Mohamed SF, Yassin MA.   +7 more
europepmc   +1 more source

Myeloma-Associated Sporadic Late-Onset Nemaline Myopathy, Successfully Treated with Daratumumab Based Induction and Autologous Stem Cell Transplantation: A Case Report. [PDF]

EJHaem
Moriwaki K, Kawano Y, Nakajima M, Nishimura N, Ueda M, Yasunaga JI.   +5 more
europepmc   +1 more source

Limited lenalidomide exposure and access to rescue plerixafor can eliminate haemopoietic progenitor cell collection failure in multiple myeloma patients treated with bortezomib, lenalidomide and dexamethasone. [PDF]

Intern Med J
Matsamakis N, Berry M, Buehler J, Zantomio D.   +3 more
europepmc   +1 more source

T-Cell Redirecting Antibodies for the Treatment of Multiple Myeloma: Off-the-Shelf T-Cell Immunity. [PDF]

Cancer J
van de Donk NWCJ, Smits F, O'Neill C, Hoekman J, Kruyswijk S, Baglio SR, Zweegman S, Korst CLBM.   +7 more
europepmc   +1 more source

Real-World Treatment Patterns and Physician Perspectives in Relapsed/Refractory Multiple Myeloma: Results From a Nationwide Italian GIMEMA Survey. [PDF]

EJHaem
Fazio F, Piciocchi A, de Fabritiis P, Messina M, Soddu S, Sargentini V, Di Raimondo F, Patriarca F, Musto P, Offidani M, Zamagni E, Bringhen S, Gentile M, Mele G, Fazi P, Petrucci M, Cavo M.   +16 more
europepmc   +1 more source

Erythema multiforme-like drug eruption in a patient with mycosis fungoides on durvalumab and lenalidomide. [PDF]

JAAD Case Rep
Crisan LL, Quach J, Zain J, Rosen ST, Querfeld C.   +4 more
europepmc   +1 more source

Severe plaque psoriasis exacerbation during lenalidomide maintenance after autologous stem cell transplantation for multiple myeloma. [PDF]

JAAD Case Rep
Mousa AM, Mahmoud-Katheer M, El Hariri M, Khazal M, Khudadah K, AlShuraiaan GM.   +5 more
europepmc   +1 more source

Carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) induction prior to autologous haematopoietic stem cell transplant/transplantation in newly diagnosed multiple myeloma. [PDF]

Br J Haematol
Marcoux C, Milton DR, Tanner MR, Bashir Q, Srour S, Saini N, Lin P, Ramdial J, Nieto Y, Ahmed S, Deeba RE, Tang G, Aljawai Y, Lee HC, Patel KK, Gaballa MR, Kebriaei P, Thomas SK, Orlowski RZ, Champlin RE, Shpall EJ, Qazilbash MH, Pasvolsky O.   +22 more
europepmc   +1 more source